University of Georgia
Researchers at the
University of Georgia and Sanofi Pasteur, the vaccines division of Sanofi,
announced today the development of a vaccine that protects against multiple
strains of both seasonal and pandemic H1N1 influenza in mouse models. They
published their findings recently in the Journal of Virology.
"One of the
problems with current influenza vaccines is that we have to make predictions
about which virus strains will be most prevalent every year and build our
vaccines around those predictions," said Ted Ross, director of UGA's
Center for Vaccines and Immunology and Georgia Research Alliance Eminent
Scholar in Infectious Diseases in the College of Veterinary Medicine.

